Related Experiment Video

Updated: May 8, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

[Vascular risk factors for Alzheimer's disease]

O S Levin, N A Trusova

    Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
    |September 3, 2013
    PubMed

    Insights

    Vascular factors contribute to Alzheimer's disease (AD) development. Early intervention targeting these factors in middle age may reduce AD risk and offer new prevention strategies.

    Area of Science:

    • Neurology
    • Cardiovascular Science
    • Gerontology

    Context:

    • Emerging research highlights the significant role of vascular factors in both cerebrovascular diseases and Alzheimer's disease (AD).
    • The precise mechanisms linking vascular risk factors to AD pathogenesis are not yet fully understood.
    • Previous studies evaluating treatments like antihypertensives, statins, and aspirin in AD patients have not demonstrated significant neuroprotection.

    Purpose:

    • To explore the role of various vascular risk factors in the pathogenesis of Alzheimer's disease (AD).
    • To emphasize the importance of understanding these mechanisms for potential AD prevention strategies.

    Summary:

    • Vascular factors are increasingly recognized as contributors to Alzheimer's disease (AD) development.
    • Despite a lack of demonstrated neuroprotection from certain treatments in established AD, factors such as hypertension, diabetes mellitus, metabolic syndrome, hyperlipidemia, hyperhomocysteinemia, obesity, atherosclerosis, atrial fibrillation, and smoking are implicated in AD pathogenesis.
    • Investigating these vascular factors is crucial for developing effective AD prevention strategies.

    Impact:

    • Understanding the link between vascular health and AD can lead to novel preventative approaches.
    • Timely modification of vascular risk factors during middle age may significantly reduce the future risk of developing Alzheimer's disease.
    • This research opens new avenues for Alzheimer's disease prevention through vascular health management.

    More Related Videos

    A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis05:12

    A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

    Published on: November 22, 2024

    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly12:50

    Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

    Published on: April 14, 2014

    Related Concept Videos

    Dementia l: Introduction01:22

    Dementia l: Introduction

    Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
    Alzheimer Disease ll: Pathophysiology01:23

    Alzheimer Disease ll: Pathophysiology

    Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
    Alzheimer Disease l: Introduction01:29

    Alzheimer Disease l: Introduction

    Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
    Alzheimer's Disease: Overview01:26

    Alzheimer's Disease: Overview

    Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
    The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    Dementia01:30

    Dementia

    Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
    The progression of dementia is generally gradual.